
A phase 3 trial presented at ASTRO 2026 found that giving focused radiation in three to five sessions, instead of one, lowered the chance of cancer returning at the surgery site, and patients lived longer.
KidneyCAN held a Town Hall in January to discuss the latest research in kidney cancer with leading experts.
KidneyCAN held a Town Hall in January to discuss the latest research in kidney cancer with leading experts. Dr. Martin Voss, a medical oncologist with Memorial Sloan Kettering Cancer Center, presented some of the biggest 2021 breakthroughs and discussed their impact on treatment options for patients. Dr. Robert Uzzo, a urologic surgeon with Fox Chase Cancer Center, discussed 2022 kidney cancer research -- what we can expect from the year ahead.
If you missed the event live, you can watch it on our website here:






